Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Intestinal Strictures in Crohn's Disease
NCT01986127Phase 3Terminated
- Sponsor
- Grifols
- Start
- Feb 2014
- Primary completion
- Jun 2018
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 3 trial of adalimumab in Crohn's disease, sponsored by Grifols. Started Feb 2014; status: terminated.
02
Drugs
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT01986127.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01986127.